Johnson & Johnson (JNJ) Latest News

NYSE Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$151.63

north_east

$2.94 (1.98%)

Day's range

$148.19

$152.35

Latest News of JNJ

JNJ vs. PFE: Which Drug Giant is a Better Buy Now?

JNJ vs. PFE: Which Drug Giant is a Better Buy Now?

By Yahoo! Finance | 1 week ago

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

By Yahoo! Finance | 1 week ago

What's Next For JNJ Stock?

What's Next For JNJ Stock?

By Forbes | 1 week ago

Lucid, Johnson & Johnson, PVH: Market Minute

Lucid, Johnson & Johnson, PVH: Market Minute

By Yahoo! Finance | 1 week ago

RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar

RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar

By Yahoo! Finance | 1 week ago

Jim Cramer on Johnson & Johnson (NYSE:JNJ): Their Spinoff Was Ill-Advised

Jim Cramer on Johnson & Johnson (NYSE:JNJ): Their Spinoff Was Ill-Advised

By Yahoo! Finance | 2 weeks ago

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case

By Yahoo! Finance | 2 weeks ago

Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years

Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years

By Yahoo! Finance | 3 weeks ago

JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease

JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease

By Yahoo! Finance | 3 weeks ago

Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific

Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific

By Yahoo! Finance | 3 weeks ago

Johnson & Johnson (NYSE:JNJ) Gains FDA Fast Track For Nipocalimab In Treating Sjogren's Disease

Johnson & Johnson (NYSE:JNJ) Gains FDA Fast Track For Nipocalimab In Treating Sjogren's Disease

By Yahoo! Finance | 3 weeks ago

An AI imaging firm says Johnson & Johnson stole its tech. Execs on both sides are expected to testify next week.

An AI imaging firm says Johnson & Johnson stole its tech. Execs on both sides are expected to testify next week.

By Yahoo! Finance | 4 weeks ago

Johnson & Johnson (JNJ) Stock Forecasts

Johnson & Johnson (JNJ) Stock Forecasts

By Yahoo! Finance | 1 month ago

JNJ Halts Development of Depression Drug Over Efficacy Concerns

JNJ Halts Development of Depression Drug Over Efficacy Concerns

By Yahoo! Finance | 1 month ago

Johnson & Johnson (JNJ): Among the Best S&P 500 Dividend Stocks to Buy Now

Johnson & Johnson (JNJ): Among the Best S&P 500 Dividend Stocks to Buy Now

By Yahoo! Finance | 1 month ago